17.02.2025 Munich – The medical technology company ADVITOS has reorganised its shareholder structure. The previous main shareholder has taken over the company as sole shareholder and will continue to support ADVITOS in the long term. The reorganisation initiated at the end of June 2024 as part of insolvency proceedings has thus been successfully completed: The […]
ADVITOS successfully completes reorganisation Read More »
17.12.2024 Munich – ADVITOS presents new generation of device for fully integrated extracorporeal blood purification at the DIVI Congress 2024 ADVITOS presented the latest generation of its innovative ADVOS system, the ADVOS BK300, at this year’s DIVI Congress (Congress of the German Interdisciplinary Association for Intensive Care and Emergency Medicine) in Hamburg. Under the motto
ADVOS BK300: Next Level Blood Purification Read More »
09.08.2024 Munich – Invitation to the product launch of the next generation of the ADVOS system! Join the event! In 117 days, the time has finally come! ADVITOS has reached the next milestone in the company’s history and we would like to share this revolutionary development with you. We are pleased to invite you to
Product Launch of the Next Generation of the ADVOS System Read More »
